Structural and functional aspects of G protein-coupled receptor oligomerization

Biochemistry and Cell Biology

Volumn 76, Issue 1, 1998, Pages 1-11

  Hébert, Terence E ^a,b   Bouvier, Michel ^b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adrenergic; Dimerization; G proteins; Receptors; Signal transduction

Indexed keywords

AMINO ACID; BIOGENIC AMINE; CELL SURFACE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LIPID; NUCLEOSIDE; PEPTIDE DERIVATIVE; POLYPEPTIDE; RECEPTOR PROTEIN;

CELL DIFFERENTIATION; CELL GROWTH; CELL METABOLISM; CELL SECRETION; DIMERIZATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; MOLECULAR INTERACTION; NEUROTRANSMISSION; NONHUMAN; OLIGOMERIZATION; PEPTIDE MAPPING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

EID: 0038646059     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o98-012     Document Type: Review

References (83)

1. Alblas, J., van Etten, I., Khanum, A., and Moolenaar, W.H. 1995. C-terminal truncation of the neurokinin-2 receptor causes enhanced and sustained agonist-induced signaling. Role of receptor phosphorylation in signal attenuation. J. Biol. Chem. 270: 8944-8951.
2. Ali, S., Richardson, R.M., Tomhave, E.D., DuBose, R.A., Haribabu, B., and Snyderman, R. 1994. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. J. Biol. Chem. 269: 24 577-24 563.
3. Amaya, E., Musci, T.J., and Kirschner. M.W. 1991. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell, 66: 257-270.
4. Avissar, S., Amitai, G., and Sokolovsky, M. 1983. Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: subunit assembly may explain high-and low-affinity agonist states. Proc. Natl. Acad. Sci. U.S.A. 80: 156-159.
5. Biemann, H.-P., and Koshland, D.E., Jr. 1994. Aspartate receptors of Exchericia coli and Salmonella typhimurium bind ligand with negative and half-of-the-sites cooperativity. Biochemistry, 33: 629-634.
6. Bishayee, S., Majumdar, S., Khire, J., and Das, M. 1989 Ligand-induced dimerization of the platelet-derived growth factor receptor. J. Biol. Chem. 264: 11 699-11 705.
7. Bormann, B.-J., Knowles, W.J., and Marchesi, V.T.J. 1989. Synthetic peptides mimic the assembly of transmembrane glycoproteins. J. Biol. Chem. 264: 4033-4037.
8. Bouvier, C., Potier, M., Beauregard, G., Lafond, J., Amlaiky, N., Caron, M.G., and Collu, R. 1986. Solubilization and characterization of D2-dopamine receptors in an estrone-induced, prolactin-secreting rat pituitary adenoma. J. Neurochem. 47: 1653-1660.
9. Chidiac, P., Green, M.A., Pawagi, A.B., and Wells, J.W. 1997. Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity. Biochemistry, 36: 7361-7379.
10. Conn, P.M., and Venter, J.C. 1985. Radiation inactivation (target size analysis) of the gonadotropin-releasing hormone receptor: evidence for a high molecular weight complex. Endocrinology, 116: 1324-1326.
11. Conn, P.M., Rogers, D.C., Stewart. J.M., Niedel, J., and Sheffield, T. 1982. Conversion of a gonadotropin-releasing hormone antagonist to an agonist. Nature (London), 296: 653-655.
12. Cvejic, S., and Devi, L.A. 1997. Dimerization of the δ-opioid receptor: implication for a role in receptor internalization. J. Biol. Chem. 272: 26 959-26 964.
13. Debburman, S.K., Kunapuli, P., Benovic, J.L., and Hosey, M.M. 1995. Agonist-dependent phosphorylation of human muscarinic receptors in Spodoptera frugiperda insect cell membranes by G protein-coupled receptor kinases. Mol. Pharmacol. 47: 224-233.
14. de Vos, A., Ultsch, M., and Kosiakoff, A.A. 1992. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science (Washington, D.C.), 255: 306-312.
15. Frame, L.T., Yeung, S.M., Venter, J.C., and Cooper, D.M. 1986. Target size of the adenosine A1 receptor. Biochem. J. 235: 621-624.
16. Fraser, C.M., and Venter, J.C. 1982. The size of the mammalian lung beta 2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography. Biochem. Biophys. Res. Commun. 109: 21-29.
17. Giannini, E., Brouchon, L., and Boulay, F. 1995. Identification of the major phosphorylation sites in human C5a anaphylatoxin receptor in vivo. J. Biol. Chem. 270: 19 166-19 172.
18. Gouldson, P.R., and Reynolds, C.A. 1997. Simulations on dimeric peptides: evidence for domain swapping in G protein-couples receptors? Biochem. Soc. Trans. 25: 1066-1071.
19. Green, M.A., Chidiac, P., and Wells., J.W. 1997. Cardiac muscarinic receptors. Relationship between the G protein and multiple states of affinity. Biochemistry, 36: 7380-7394.
20. Greenlund, A.C., Schreiber, R., Goeddel, D.V., and Pennica, D. 1993. Inteferon-γ induces receptor dimerization in solution and on cells. J. Biol. Chem. 268: 18 103-18 110.
21. Gregory, H., Taylor, C.L., and Hopkins, C.R. 1982. Luteinizing hormone release from dissociated pituitary cells by dimerization of occupied LHRH receptors. Nature (London), 300: 269-271.
22. Grewal, N., Hagpal, S., Chavali, G.B., Majumdar, S.S., Pal, R., and Salunke, D.M. 1997. Ligand-indueed receptor dimerization may be critical for signal transduction by choriogonadotropin. Biophys. J. 73: 1190-1197.
23. Hazum, E., and Keinun, D. 1985. Gonadotropin releasing hormone activation is mediated by dimerization of occupied receptors. Biochem. Biophys. Res. Commun. 133: 449-456.
24. 2AR transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271: 16 384-16 392.
25. 2AR through receptor dimerization. Biochem. J. 330: 287-293.
26. Heldin, C.-H., Ernlund, A., Rorsman, C., and Ronnstrand, L. 1989. Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. J. Biol. Chem. 264: 8905-8912.
27. Herberg, J.T., Codina, J., Rich, K.A., Rojas, F.J., and Iyengar, R. 1984. The hepatic glucagon receptor: solubilization, characterization, and development of an affinity adsorption assay for the soluble receptor. J. Biol. Chem. 259: 9285-9294.
28. Hinko, A., Soloff, M.S., and Potier, M. 1992. Molecular size characterization of oxytocin receptors in rabbit amnion. Endocrinology, 130: 3554-3559.
29. Hirschberg, B.T., and Schimerlik, M.I. 1994. A kinetic model for oxotremorine M binding to recombinantporcine m2 muscarinic receptors expressed in Chinese hamster ovary cells. J. Biol. Chem. 269: 26 127-26 135.
30. Kent, U.T., Mao, S.-Y., Wofsy, C., Goldstein, B., Ross, S., and Metzger, H. 1994. Dynamics of signal transduction after aggregation of cell-surface receptors: studies on the type I receptor for IgE. Proc. Natl. Acad. Sci. U.S.A. 91: 3087-3091.
31. Kim, S.-H. 1994. "Frozen" dynamic dimer model for transmembrane signaling in bacteria chemotaxis receptors. Protein Sci. 3: 159-165.
32. Lemmon, M.A., Flanagan, J.M., Hunt, J.F., Adair, B.D., Bormann, B.-J., Dempsey, C.E., and Engelman, D.A. 1992a. Glycophorin A dimerization is driven by specific interactions between transmembrane α-helices. J. Biol. Chem. 267: 7683-7689.
33. Lemmon, M.A., Flanagan, J.M., Treutlein, H.R., Zhang, J., and Engelman, D.M. 1992b. Sequence specificity in the dimerization of transmembrane α-helices. Biochemistry, 31: 12 719-12 725.
34. Lemmon, M.A., Treutlein, H.R., Adams, P.D., Brünger, A.T., and Engelman, D.A. 1994. A dimerization motif for transmembrane α-helices. Nat. Struct. Biol. 1: 157-163.
35. Lilly, L., Fraser, C.M., Jung, C.Y., Seeman, P., and Venter, J.C. 1983. Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation. Mol. Pharmacol. 24: 10-14.
36. Limbird, L.E., Meyts, P.D., and Lefkowitz, R.J. 1975. Beta-adrenergic receptors: evidence for negative cooperativity. Biochem. Biophys. Res. Commun. 64: 1160-1168.
37. Long, D.G., and Weis, R.M. 1992. Oligomerization of the cytoplasmic fragment from the aspartate receptor of Escherichia coli. Biochemistry, 31: 9904-9911.
38. MacKenzie, K.R., Prestegard, J.H., and Engelman, D.M. 1997. A transmembrane helix dimer: structure and implications. Science (Washington, D.C.), 276: 131-133.
39. Maggio, R., Vogel, Z., and Wess, J. 1993. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. Proc. Natl. Acad. Sci. U.S.A. 90: 3103-3107.
40. Maggio, R., Barbier, P., Fornai, F., and Corsini, G.U. 1996. Functional role of the third intracellular loop in muscarinic receptor dimerization. J. Biol. Chem. 271: 31 055-31 060.
41. Mattera, R., Pitts, B.J.R., Entman, M.L., and Birnbaumer, L. 1985. Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system: evidence for homo-and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting. J. Biol. Chem. 260: 7410-7421.
42. Milligan, D.L., and Koshland, D.E., Jr. 1991. Intrasubunit signal transduction by the aspartate chemoreceptor. Science (Washington, D.C.), 254: 1651-1653.
43. Moffett, S., Mouillac, B., Bonin, H., and Bouvier, M. 1993. Altered phosphorylation and desensitization patterns of a human β2-adrenergic receptor lacking the palmitoylated Cys341. EMBO J. 12: 349-356.
44. 2 AR by the cAMP-dependent protein kinase. J. Biol. Chem. 271: 21 490-21 497.
45. Monnot, C., Bihoreau, C., Conchon, C., Curnow, K.M., Corvol, P., and Clauser, E. 1996. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J. Biol. Chem. 271: 1507-1513.
46. Nekrasova, E., Sosinskaya, A., Natochin, M., Lancet, D., and Gat, U. 1996. Overexpression, solubilization and purification of rat and human olfactory receptors. Eur. J. Biochem. 238: 28-37.
47. Ng, G.Y.K., George, S.R., Zastawny, R., Caron, M., Dennis, M., and O'Dowd, B.F. 1993. Human serotonin IB receptor expression in Sf9 cells: phosphorylation, palmitoylation, and adenylyl cyclase inhibition. Biochemistry, 32: 11 727-11 733.
48. L dopamine receptor in Sf9 cells. J. Neurochem. 63: 1589-1595.
49. Ng, G.Y.K., Mouillac, B., George, S.R., Caron, M., Dennis, M., Bouvier, M., and O'Dowd, B.F. 1994b. Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. Eur. J. Pharmacol. 267: 7-19.
50. Ng, G.Y.K., O'Dowd, B.F., Lee, S.P., Chung, H.P., Brann, M.R., Seeman, P., and George, S.R. 1996. Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem. Biophys. Res. Commun. 227: 200-204.
51. Nielsen, T.B., Lad, P.M., Preston, M.S., Kempner, E., Schlegel, W., and Rodbell, M. 1981. Structure of the turkey erythrocyte adenylate cyclase system. Proc. Natl. Acad. Sci. U.S.A. 78: 722-726.
52. 11C] N-methylspiperone. Psychiatry Res. Neuroimaging, 61: 67-83.
53. O'Dowd, B.F., Hnatowich, M., Caron, M.G., Lefkowitz, R.J., and Bouvier, M. 1989. Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an un-coupled nonpalmitoylated form of the receptor. J. Biol. Chem. 264: 7564-7569.
54. Osuga, Y., Hayashi, M., Kudo, M., Conti., M., Kobilka, B., and Hsueh, A.J.W. 1997. Co-expression of defective luteinizing hormone receptor fragments partially reconstitutes ligand-induced signal generation. J. Biol. Chem. 272: 25 006-25 012.
55. Peterson, G.L., Rosenbaum, L.C., Broderick, D.J., and Schimerlik, M.I. 1986. Physical properties of the purified cardiac muscarinic acetylcholine receptor. Biochemistry, 25: 3189-3202.
56. Pickering, D.S., Thomsen, C., Suzdak, P.D., Fletcher, E.J., Robitaille, R., Salter, M.W., MacDonald, J.F., Huang, X.-P., and Hampson, D.R. 1993. A comparison of two alternatively spliced forms of a metabotropic glutamate receptor coupled to phosphoinositide turnover. J. Neurochem. 61: 85-92.
57. Podesta, E.J., Solano, A.R., Attar, R., Sanchez, M.L., and Vedia, L.M. 1983. Receptor aggregation induced by antilutropin antibody and biological response in rat Leydig cells. Proc. Natl. Acad. Sci. U.S.A. 80: 3986-3990.
58. Podesta, E.J., Solano, A.R., and Sanchez, M.L. 1986. Luteinizing hormone triggers two opposite regulatory pathways through an initial common event, receptor aggregation. Endocrinology. 119: 989-997.
59. Potter, L.T., Ballesteros, L.A., Bichijian, L.H., Ferrendelli, C.A., Fisher, A., Hanchett, H.E., and Zhang, R. 1991. Evidence for paired M2 muscarinic receptors. Mol. Pharmacol. 39: 211-221.
60. Romano, C., Yang., W.-L., and O'Malley, K.L. 1996. Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J. Biol. Chem. 271: 28 612-28 616.
61. Schöneberg, T., Yun. J., Wenkert, D., and Wess, J. 1996. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by co-expressed receptor polypeptide. EMBO J. 15: 1283-1291.
62. Schöneberg, T., Sandig, V., Wess, J., Gudermann, T., and Schultz, G. 1997. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. J. Clin. Invest. 100: 1547-1556.
63. Schreurs, J., Yamamoto, R., Lyons, J., Munemitsu, S., Conroy, L., Clark, R., Takeda, Y., Krause, J.E., and Innes, M.J. 1995. Functional wild-type and carboxy-terminal-tagged rat substance P receptors expressed in baculovirus-infected insect Sf9 cells. J. Neurochem. 64: 1622-1631.
64. Seeman, P., and Van Tol, H.H.M. 1994. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15: 264-270.
65. Seeman, P., Guan, H.-C., Civelli, O., Van Tol, H.H.M., Sunahara, R.K., and Niznik, H.B. 1992. The cloned dopamine D2 receptor reveals different densities for dopamine antagonist ligands. Implications for human brain positron emission tomography. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 227: 139-146.
66. Seifert, R.A., Hart, C.E., Phillips, P.E., Forstrom, J.W., Ross, R., Murray, M.J., and Bowen-Pope, D.F. 1989. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J. Biol. Chem. 264: 8771-8778.
67. 3H|histamine in guinea pig cerebral cortex. II. Mechanistic basis for multiple states of affinity. Mol. Pharmacol. 43: 583-594.
68. 3H]histamine in guinea pig cerebral cortex. I. Pharmacological characterization. Mol. Pharmacol. 43: 569-582.
69. Sorokin, A., Lemmon, M.A., Ullrich, A., and Schlessinger, J. 1994. Stabilization of an active form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond. J. Biol. Chem. 269: 9752-9759.
70. Stock, J.B., Lukat, G.S., and Stock, A.M. 1991. Bacterial chemotaxis and the molecular logic of intracellular signal transduction networks. Annu. Rev. Biophys. Biophys. Chem. 20: 109-136.
71. Strange, P.G. 1994. Dopamine D4 receptors: curiouser and curiouser. Trends. Pharmacol. Sci. 15: 317-319.
72. Vasudevan, S., Hulme, B.C., Bach, M., Haase, W., Pavia, J., and Reila"nder, H. 1995. Characterization of the rat m3 muscarinic acetylcholine receptor produced in insect cells infected with recombinant baculoviruses. Eur. J. Biochem. 227: 466-475.
73. Venter, J.C. 1983. Muscarinic cholinergic receptor structure. Receptor size, membrane orientation, and absence of major phy logenetic structural diversity. J. Biol. Chem. 258: 4842-4848.
74. Venter, J.C., Schaber, J.S., U'Prichard, D.C., and Fraser, C.M. 1983. Molecular size of the human platelet alpha 2-adrenergic receptor as determined by radiation inactivation. Biochem. Biophys. Res. Commun. 116: 1070-1075.
75. Venter, J.C., Home, P., Eddy, B., Greguski, R., and Fraser, C.M. 1984. Alpha 1-adrenergic receptor structure. Mol. Pharmacol. 26: 196-205.
76. Wade, S.M., Dalman, H.M., Yang, S.Z., and Neubig, R.R. 1994. Multisite interactions of receptors and G proteins: enhanced potency of dimeric receptor peptides in modifying G protein function. Mol. Pharmacol. 45: 1191-1197.
77. Walter, M.R., Windsor, W.T., Nagabhushan, T.L., Lundell. D.J., Lunn, C.A., Zauodny, P.J., and Narula, S.K. 1995. Crystal structure of a complex between inteferon-γ and its soluble high-affinity receptor. Nature (London), 376: 230-235.
78. Wang, N.P., Fukui, H., Matsuoka, H., and Wada, H. 1986. Determination of the molecular size of the hepatic H1-receptor by target size analysis. Biochem. Biophys. Res. Commun. 137: 593-598.
79. Wessling-Resniek, M., and Johnson, G.L. 1987. Allosteric behaviour in transducin activation mediated by rhodopsin. J. Biol. Chem. 262: 3697-3705.
80. Willardson, B.M., Pou, B., Yoshida, T., and Bitensky, M.W. 1993. Cooperative binding of the retinal rod G-protein, transducin to light-activated rhodopsin. J. Biol. Chem. 268: 6371-6382.
81. Wreggett, K.A., and Wells, J.W. 1995. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J. Biol. Chem. 270: 22 488-22 499.
82. Yarden, Y., and Schlessinger, J. 1987a. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry, 26: 1434-1442.
83. Yarden, Y., and Schlessinger, J. 1987b. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry, 26: 1443-1451.